Source: HIT Consultant Media

myTomorrows: myTomorrows Introduces Next-Generation AI Platform for Precision Trial Matching

What You Should Know: - myTomorrows, a global health technology company connecting patients and physicians with all possible pre-approval treatment options, today announced the launch of its next-generation AI platform. - Designed to streamline clinical trial recruitment, the platform supercharges how physicians search, pre-screen, and refer patients - helping trial sponsors accelerate enrollment, enhance diversity, and ... Read More

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Ronald Brus's photo - Founder & CEO of myTomorrows

Founder & CEO

Ronald Brus

CEO Approval Rating

78/100

Read more